Gennvax, Egypt’s pioneering vaccine manufacturing site, is dedicated to achieving self-sufficiency in core vaccines and contributing to Africa’s health security. In alignment with its vision to locally produce a significant share of the continent’s vaccine needs, Gennvax has embarked on its journey toward market access across Africa.

As a proud member of the Egyptian Vaccines Manufacturers Association (EVMA), Gennvax embraces its role in fostering regional collaboration and strengthening Africa’s biomanufacturing ecosystem. The company’s first destination on this strategic journey was Zimbabwe, where it received full support from Egypt’s Ministry of Foreign Affairs and the Egyptian Ambassador to Zimbabwe.

During a high-level meeting with Zimbabwe’s Ministry of Health and Child Care, Gennvax was honored to sign an Expression of Interest (EOI) with the Honorable Dr. Douglas Mombeshora, Minister of Health.

This agreement marks the beginning of a collaborative partnership aimed at:

• Facilitating access to vaccines within Gennvax’s portfolio to address Zimbabwe’s national health needs.

• Supporting technical training and knowledge exchange for Zimbabwean health professionals.

• Exploring opportunities for local capacity building, including potential technology transfer.

• Strengthening regulatory and quality assurance capabilities in vaccine evaluation and monitoring.

This milestone reflects Gennvax’s commitment to advancing vaccine equity, promoting regional self-reliance, and contributing to a healthier, more resilient Africa.

High-level meeting with Zimbabwe’s Ministry of Health and Child Care, Gennvax was honored to sign an Expression of Interest (EOI) with the Honorable Dr. Douglas Mombeshora, Minister of Health